High Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients

Adjuvant chemotherapy is commonly given to surgically treated non-small-cell lung cancer (NSCLC) patients. However, the prerequisite for chemotherapy needs to be scrutinized in order to maximize the benefits to patients. In this study, we observed that NSCLC cells with high Id1 protein expression we...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yu-Jen, Lee, Yi-Chen, Chiu, Wen-Chin, Tsai, Jen-Wei, Su, Yu-Han, Hung, Amos C., Chang, Po-Chih, Huang, Chih-Jen, Chai, Chee-Yin, Yuan, Shyng-Shiou F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294339/
https://www.ncbi.nlm.nih.gov/pubmed/25344919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294339/
https://www.ncbi.nlm.nih.gov/pubmed/25344919

Ejemplares similares